Back to Results
First PageMeta Content
Annual report / Bevacizumab / SEC filings / Form 10-K / Government procurement in the United States


Focus and value creation Severin Schwan, CEO Roche Group London, September 2014
Add to Reading List

Document Date: 2014-10-08 08:00:02

Open Document

File Size: 1,08 MB

Share Result on Facebook

City

London / /

Company

INTERMUNE / Roche Group / Seragon / IQuum & Genia / KLEE ACQUISITION CORPORATION / /

Country

United States / /

Event

M&A / FDA Phase / /

MedicalCondition

cervical cancer / /

Organization

Pharma Division Diagnostics Division / Securities and Exchange Commission / UNITED STATES SECURITIES AND EXCHANGE COMMISSION / /

Person

Severin Schwan / /

Position

CEO / Governor / /

Product

Pegasys / Xeloda / Herceptin / Avastin / Rituxan / Lucentis / Xolair / CellCept / Tarceva / LptD3 / /

URL

WWW.SEC.GOV / WWW.INTERMUNE.COM / www.roche.com / /

SocialTag